Market Overview:
The global Phacoemulsification Device market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cataracts, technological advancements in phacoemulsification devices, and rising demand for minimally invasive surgeries. Based on type, the global Phacoemulsification Device market is segmented into diagnostic devices and therapeutic devices. The diagnostic devices segment is further sub-segmented into manual phacoemulsification device and automated phacoemulsification device. The therapeutic devices segment is further sub-segmented into monofocal lens implantation device, toric lens implantation device, and multifocal lens implantation device. Based on application, the global Phacoemulsification Device market is divided into hospitals & clinics, homecare settings, and ambulatory care centers.
Product Definition:
A phacoemulsification device is a medical device used to break up and aspirate cataracts from the eye. The importance of the device is that it allows for the removal of cataracts in a minimally invasive way, which can lead to improved patient outcomes.
Diagnostic Device:
A diagnostic device is a medical device used for the diagnosis of diseases and conditions. It helps in determining the cause of disease by providing information about possible disorders or malformations. Diagnostic devices find their application in ophthalmology, cardiology, orthopedics, gastroenterology and many other fields.
Therapeutic Device:
Therapeutic devices are used in the treatment of diseases and disorders. These devices are classified into two major categories, which include surgical/invasive therapeutic devices and non-surgical/minimally invasive therapeutic devices.
Application Insights:
Based on application, the global phacoemulsification device market is segmented into hospitals and clinics, homecare, and ambulatory care centers. Hospitals and clinics dominated the overall market in terms of revenue in 2017 owing to factors such as a high prevalence of cataract-related disorders coupled with rising geriatric population at risk of developing these disorders. In addition, an increase in number of surgeries being performed at a time increases demand for phacoemulsification devices.
The homecare segment is expected to grow significantly over the forecast period due to increasing geriatric population across the globe which results in eye diseases becoming more common among them. For instance, according to data published by WHO Ophthalmic Services Training & Education Global Report 2018 shows that out of 1 billion people aged 60 years or above globally; around 54% have some form of visual impairment whereas 32% are blind due to it.
Regional Analysis:
North America dominated the global phacoemulsification device market in 2017. This can be attributed to the increasing prevalence of cataract, rising geriatric population, and high per capita healthcare expenditure. In addition, favorable reimbursement policies for ophthalmic care are also expected to drive regional growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to an increase in diabetic retinopathy patients and aging population along with a rise in awareness about early diagnosis of eye diseases.
Growth Factors:
- Technological advancements in the field of phacoemulsification devices that can make the surgery safer and more efficient.
- Increasing demand for cataract surgeries due to rising incidence of cataracts and aging population.
- Growing awareness about the benefits of phacoemulsification surgery among patients and surgeons alike.
- Rising healthcare expenditure by governments and private players across the globe, which is likely to boost demand for phacoemulsification devices over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Phacoemulsification Device Market Research Report
By Type
Diagnostic Device, Therapeutic Device
By Application
Hospitals & Clinics, Homecare, Ambulatory Care Center
By Companies
ABBOTT, ALCON, Essilor International, Bausch & Lomb, Topcon Corporation, Carl Zeiss Meditec AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Phacoemulsification Device Market Report Segments:
The global Phacoemulsification Device market is segmented on the basis of:
Types
Diagnostic Device, Therapeutic Device
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Clinics, Homecare, Ambulatory Care Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ABBOTT
- ALCON
- Essilor International
- Bausch & Lomb
- Topcon Corporation
- Carl Zeiss Meditec AG
Highlights of The Phacoemulsification Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostic Device
- Therapeutic Device
- By Application:
- Hospitals & Clinics
- Homecare
- Ambulatory Care Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Phacoemulsification Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A phacoemulsification device is a medical device that uses high-pressure water and an electric current to break up clumps of tissue in the eye. This helps to remove debris and foreign objects that may be causing vision problems.
Some of the major players in the phacoemulsification device market are ABBOTT, ALCON, Essilor International, Bausch & Lomb, Topcon Corporation, Carl Zeiss Meditec AG.
The phacoemulsification device market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Phacoemulsification Device Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Phacoemulsification Device Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Phacoemulsification Device Market - Supply Chain
4.5. Global Phacoemulsification Device Market Forecast
4.5.1. Phacoemulsification Device Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Phacoemulsification Device Market Size (000 Units) and Y-o-Y Growth
4.5.3. Phacoemulsification Device Market Absolute $ Opportunity
5. Global Phacoemulsification Device Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Phacoemulsification Device Market Size and Volume Forecast by Type
5.3.1. Diagnostic Device
5.3.2. Therapeutic Device
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Phacoemulsification Device Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Phacoemulsification Device Market Size and Volume Forecast by Application
6.3.1. Hospitals & Clinics
6.3.2. Homecare
6.3.3. Ambulatory Care Center
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Phacoemulsification Device Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Phacoemulsification Device Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Phacoemulsification Device Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Phacoemulsification Device Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Phacoemulsification Device Demand Share Forecast, 2019-2026
9. North America Phacoemulsification Device Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Phacoemulsification Device Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Phacoemulsification Device Market Size and Volume Forecast by Application
9.4.1. Hospitals & Clinics
9.4.2. Homecare
9.4.3. Ambulatory Care Center
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Phacoemulsification Device Market Size and Volume Forecast by Type
9.7.1. Diagnostic Device
9.7.2. Therapeutic Device
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Phacoemulsification Device Demand Share Forecast, 2019-2026
10. Latin America Phacoemulsification Device Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Phacoemulsification Device Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Phacoemulsification Device Market Size and Volume Forecast by Application
10.4.1. Hospitals & Clinics
10.4.2. Homecare
10.4.3. Ambulatory Care Center
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Phacoemulsification Device Market Size and Volume Forecast by Type
10.7.1. Diagnostic Device
10.7.2. Therapeutic Device
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Phacoemulsification Device Demand Share Forecast, 2019-2026
11. Europe Phacoemulsification Device Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Phacoemulsification Device Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Phacoemulsification Device Market Size and Volume Forecast by Application
11.4.1. Hospitals & Clinics
11.4.2. Homecare
11.4.3. Ambulatory Care Center
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Phacoemulsification Device Market Size and Volume Forecast by Type
11.7.1. Diagnostic Device
11.7.2. Therapeutic Device
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Phacoemulsification Device Demand Share, 2019-2026
12. Asia Pacific Phacoemulsification Device Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Phacoemulsification Device Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Phacoemulsification Device Market Size and Volume Forecast by Application
12.4.1. Hospitals & Clinics
12.4.2. Homecare
12.4.3. Ambulatory Care Center
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Phacoemulsification Device Market Size and Volume Forecast by Type
12.7.1. Diagnostic Device
12.7.2. Therapeutic Device
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Phacoemulsification Device Demand Share, 2019-2026
13. Middle East & Africa Phacoemulsification Device Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Phacoemulsification Device Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Phacoemulsification Device Market Size and Volume Forecast by Application
13.4.1. Hospitals & Clinics
13.4.2. Homecare
13.4.3. Ambulatory Care Center
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Phacoemulsification Device Market Size and Volume Forecast by Type
13.7.1. Diagnostic Device
13.7.2. Therapeutic Device
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Phacoemulsification Device Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Phacoemulsification Device Market: Market Share Analysis
14.2. Phacoemulsification Device Distributors and Customers
14.3. Phacoemulsification Device Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ABBOTT
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. ALCON
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Essilor International
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bausch & Lomb
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Topcon Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Carl Zeiss Meditec AG
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
